Case study: How research was used to forecast demand for an immunosuppressant product in development in China



The challenge
Our client planned to launch a new branded immunosuppressant in china in 3+ years time. Little reliable data was currently available. The Ministry of Health, in reaction to a new story on organ donors, overnight relinquished the licence of 60% of transplant facilities. The study required an in-depth qualitative assessment of the product profile followed by a quantification of likely uptake
research used to forecast demand for an immunosuppressant product in development in China- case study
research used to forecast demand for an immunosuppressant product in development in China- case study



The challenge
Our client planned to launch a new branded immunosuppressant in china in 3+ years time. Little reliable data was currently available. The Ministry of Health, in reaction to a new story on organ donors, overnight relinquished the licence of 60% of transplant facilities. The study required an in-depth qualitative assessment of the product profile followed by a quantification of likely uptake

The solution
We recommended a 3-stage study. In the first stage, we conducted a telephone audit of all 151 registered transplant hospitals in China to understand the size of the market. We reviewed findings and sorted hospitals by a) number of procedures b) hospital tier and c) city tier. In stage 2 we carried out qualitative IDIs to assess face to face quantitative study with physicians. It is possible to conduct interviews online but panels are still in development so therefore this method was more cost-effective.

The outputs
This 3-stage appraoch allowed us to understand the universe in detail and from there design an accurate sample frame to reflect the whole of urban China. This in turn allowed us to produce a very accurate picture by city and hospital tier of likely uptake.

 

Sign up to receive Rapport

Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research.

Sign up here